Sphingolipids and insulin resistance: the five Ws
The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: Inhibition of sphingolipid synthesis increases insulin sensitivity, resolves hepatic steatosis, and prevents the onset of diabetes in obese rodents. I herein review these interventional studies, aiming to summarize the five Ws - the 'Who, What, Where, When, and Why' questions that need to be addressed to understand roles of sphingolipids in the pathogenesis of diabetes. RECENT FINDINGS: Who: ceramides and glucosylceramides are likely to be independent antagonists of insulin action. Where: recent data suggest that ceramides may inhibit insulin action in skeletal muscle, whereas glucosylceramides may be more efficacious in adipose tissue. In contrast, sphingolipid accumulation in the liver appears to be insufficient to induce insulin resistance. What: ceramides and glucosylceramides inhibit different insulin signaling events, but it is unclear whether these actions account for the broad spectrum of therapeutic benefits resulting from sphingolipid depletion. When: recent data suggest that obesity-induced inflammation is important for the induction of sphingolipid synthesis. Why: sphingolipids have an evolutionarily conserved role to starve cells of nutrients, and the inhibition of insulin action is possibly a component of this broader action. SUMMARY: Despite considerable attention to the question of how sphingolipids induce metabolic disease, there exist enormous gaps in knowledge. Further elucidation of these molecular details will be essential for the development of new therapeutic strategies for inhibiting sphingolipid action and ameliorating metabolic diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ceramides have been linked to hepatic IR, and they inhibit several mediators of the insulin signalling pathway, such as insulin receptor substrate 1, phosphatidylinositol 3-kinase, and Akt.118”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [118]
Citations
Cites
1 retracted
Activation of Protein Phosphatase 2A by Palmitate Inhibits AMP-activated Protein Kinase
Wu, Y., Song, P., Xu, J., Zhang, M., & Zou, M.-H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608310200 · Cited by 274
RetractedCho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Holland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232
Self-citationThe Ceramide-centric Universe of Lipid-mediated Cell Regulation: Stress Encounters of the Lipid Kind
Hannun, Y. A., & Obeid, L. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200008200 · Cited by 907
Ceramide in the eukaryotic stress response
Hannun, Y. A., & Luberto, C. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01694-3 · Cited by 727
Ceramide Content Is Increased in Skeletal Muscle From Obese Insulin-Resistant Humans
Adams, J. M., Pratipanawatr, T., Berria, R., Wang, E., DeFronzo, R. A., Sullards, M. C., & Mandarino, L. J. (2004) · Diabetes · doi:10.2337/diabetes.53.1.25 · Cited by 668
Chavez, J. A., Knotts, T. A., Wang, L.-P., Li, G., Dobrowsky, R. T., Florant, G. L., & Summers, S. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212307200 · Cited by 617
Self-citationDe Novo Sphingolipid Biosynthesis: A Necessary, but Dangerous, Pathway
Merrill, A. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200009200 · Cited by 617
Holland, W. L., & Summers, S. A. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0025 · Cited by 595
Self-citationDistinct Effects of Saturated and Monounsaturated Fatty Acids on β-Cell Turnover and Function
Maedler, K., Spinas, G. A., Dyntar, D., Moritz, W., Kaiser, N., & Donath, M. Y. (2001) · Diabetes · doi:10.2337/diabetes.50.1.69 · Cited by 552
Cited by
Inflammatory links between obesity and metabolic disease
Lumeng, C. N., & Saltiel, A. R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57132 · Cited by 2,319
Inflammatory mechanisms linking obesity and metabolic disease
Saltiel, A. R., & Olefsky, J. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92035 · Cited by 2,212
Adapting to obesity with adipose tissue inflammation
Reilly, S. M., & Saltiel, A. R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.90 · Cited by 1,204
FAT SIGNALS - Lipases and Lipolysis in Lipid Metabolism and Signaling
Zechner, R., Zimmermann, R., Eichmann, T. O., Kohlwein, S. D., Haemmerle, G., Lass, A., & Madeo, F. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.018 · Cited by 1,132
Sphingosine-1-phosphate signaling and its role in disease
Maceyka, M., Harikumar, K. B., Milstien, S., & Spiegel, S. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.09.003 · Cited by 1,039
Inflammation and Lipid Signaling in the Etiology of Insulin Resistance
Glass, C. K., & Olefsky, J. M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.001 · Cited by 935
Lipid droplets and liver disease: from basic biology to clinical implications
Gluchowski, N. L., Becuwe, M., Walther, T. C., & Farese, R. V. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.32 · Cited by 677
Ceramides – Lipotoxic Inducers of Metabolic Disorders
Chaurasia, B., & Summers, S. A. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.07.006 · Cited by 616
Self-citationDiabetes, oxidative stress and therapeutic strategies
Rochette, L., Zeller, M., Cottin, Y., & Vergely, C. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.05.017 · Cited by 530
Brain metabolic dysfunction at the core of Alzheimer's disease
de la Monte, S. M., & Tong, M. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.012 · Cited by 461
Reilly, S. M., Chiang, S.-H., Decker, S. J., Chang, L., Uhm, M., Larsen, M. J., Rubin, J. R., Mowers, J., White, N. M., Hochberg, I., et al. (2013) · Nature Medicine · doi:10.1038/nm.3082 · Cited by 433
Fiehn, O., Garvey, W. T., Newman, J. W., Lok, K. H., Hoppel, C. L., & Adams, S. H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015234 · Cited by 421
Martins, A. R., Nachbar, R. T., Gorjao, R., Vinolo, M. A., Festuccia, W. T., Lambertucci, R. H., Cury-Boaventura, M. F., Silveira, L. R., Curi, R., & Hirabara, S. M. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-30 · Cited by 290
Zhang, Q.-J., Holland, W. L., Wilson, L., Tanner, J. M., Kearns, D., Cahoon, J. M., Pettey, D., Losee, J., Duncan, B., Gale, D., et al. (2012) · Diabetes · doi:10.2337/db11-1399 · Cited by 234
Self-citationSerum ceramides increase the risk of Alzheimer disease: The Women's Health and Aging Study II
Mielke, M. M., Bandaru, V. V. R., Haughey, N. J., Xia, J., Fried, L. P., Yasar, S., Albert, M., Varma, V., Harris, G., Schneider, E. B., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318264e380 · Cited by 222
Ceramide as a Mediator of Non-Alcoholic Fatty Liver Disease and Associated Atherosclerosis
Kasumov, T., Li, L., Li, M., Gulshan, K., Kirwan, J. P., Liu, X., Previs, S., Willard, B., Smith, J. D., & McCullough, A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126910 · Cited by 209
The Problem of Establishing Relationships between Hepatic Steatosis and Hepatic Insulin Resistance
Farese, R. V., Zechner, R., Newgard, C. B., & Walther, T. C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.004 · Cited by 209
Plasma Sphingomyelins are Associated with Cognitive Progression in Alzheimer's Disease
Mielke, M. M., Haughey, N. J., Bandaru, V. V. R., Weinberg, D. D., Darby, E., Zaidi, N., Pavlik, V., Doody, R. S., & Lyketsos, C. G. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110405 · Cited by 156
Leung, P. S. (2016) · Nutrients · doi:10.3390/nu8030147 · Cited by 165
Lipid metabolism in MASLD and MASH: From mechanism to the clinic
Carli, F., Della Pepa, G., Sabatini, S., Vidal Puig, A., & Gastaldelli, A. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101185 · Cited by 147
Bosma, M., Kersten, S., Hesselink, M. K. C., & Schrauwen, P. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.11.003 · Cited by 156
A Novel Function of Adipocytes in Lipid Antigen Presentation to iNKT Cells
Huh, J. Y., Kim, J. I., Park, Y. J., Hwang, I. J., Lee, Y. S., Sohn, J. H., Lee, S. K., Alfadda, A. A., Kim, S. S., Choi, S. H., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00552-12 · Cited by 129
Ceramide-Initiated Protein Phosphatase 2A Activation Contributes to Arterial Dysfunction In Vivo
Bharath, L. P., Ruan, T., Li, Y., Ravindran, A., Wan, X., Nhan, J. K., Walker, M., Deeter, L., Goodrich, R., Johnson, E., et al. (2015) · Diabetes · doi:10.2337/db15-0244 · Cited by 136
Self-citationLee, S., Hong, I., Kim, B., Shim, S., Lee, J., Lee, H., Choi, C. S., Kim, B., & Park, T. (2015) · Hepatology · doi:10.1002/hep.27804 · Cited by 125
Mechanisms of Lipotoxicity in the Cardiovascular System
Wende, A. R., Symons, J. D., & Abel, E. D. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0307-2 · Cited by 110
Turban, S., & Hajduch, E. (2011) · FEBS Letters · doi:10.1016/j.febslet.2010.12.022 · Cited by 116
Jiang, M., Li, C., Liu, Q., Wang, A., & Lei, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00665 · Cited by 122
Lipotoxicity contributes to endothelial dysfunction: A focus on the contribution from ceramide
Symons, J. D., & Abel, E. D. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-012-9235-3 · Cited by 108
Sphingolipid Metabolism, Oxidant Signaling, and Contractile Function of Skeletal Muscle
Nikolova‐Karakashian, M., & Reid, M. B. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3940 · Cited by 114
Dihydroceramide desaturase and dihydrosphingolipids: Debutant players in the sphingolipid arena
Fabriàs, G., Munoz-Olaya, J. M., Cingolani, F., Signorelli, P., Casas, J., Gagliostro, V., & Ghidoni, R. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.12.002 · Cited by 111
Clugston, R. D., Jiang, H., Lee, M. X., Piantedosi, R., Yuen, J. J., Ramakrishnan, R., Lewis, M. J., Gottesman, M. E., Huang, L.-S., Goldberg, I. J., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m017368 · Cited by 102
New therapeutic approaches for the treatment of obesity
Saltiel, A. R. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad1811 · Cited by 102
SMPDL3b modulates insulin receptor signaling in diabetic kidney disease
Mitrofanova, A. V., Mallela, S. K., Ducasa, G. M., Yoo, T., Rosenfeld-Gur, E., Zelnik, I. D., Molina, J., Santos, J. V., Ge, M., Sloan, A. J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10584-4 · Cited by 118
de la Monte, S. M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111727 · Cited by 109
A view on sphingolipids and disease
Kolter, T. (2011) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.04.013 · Cited by 120
Brozinick, J. T., Hawkins, E., Bui, H. H., Kuo, M.-S., Tan, B., Kievit, P., & Grove, K. L. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.191 · Cited by 118
Insulin Resistance in the Defense against Obesity
Saltiel, A. R. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.001 · Cited by 116
Kitessa, S., & Abeywardena, M. (2016) · Nutrients · doi:10.3390/nu8080466 · Cited by 98
Lankinen, M. A., Schwab, U., Kolehmainen, M., Paananen, J., Nygrén, H., Seppänen‐Laakso, T., Poutanen, K. S., Hyötyläinen, T., Risérus, U., Savolainen, M. J., et al. (2016) · Journal of Nutrition · doi:10.3945/jn.115.220459 · Cited by 110
Chang, X., Wang, Z., Zhang, J., Yan, H., Bian, H., Xia, M., Lin, H., Jiang, J., & Gao, X. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0982-x · Cited by 96
Cantrell, J. E. L., Morris, A. J., Sunkara, M., Popa, G. J., Larson, K., & Özcan, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.268185 · Cited by 101
Hu, W., Ross, J., Geng, T., Brice, S. E., & Cowart, L. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.186916 · Cited by 86
Regulation of sphingolipid synthesis via Orm1 and Orm2 in yeast
Liu, M. R., Huang, C., Polu, S. R., Schneiter, R., & Chang, A. (2012) · Journal of Cell Science · doi:10.1242/jcs.100578 · Cited by 108
Sphingolipid metabolism in non-alcoholic fatty liver diseases
Régnier, M., Polizzi, A., Guillou, H., & Loiseau, N. (2018) · Biochimie · doi:10.1016/j.biochi.2018.07.021 · Cited by 95
Sphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study)
Mäkinen, V., Tynkkynen, T., Soininen, P., Forsblom, C. M., Peltola, T., Kangas, A. J., Groop, P., & Ala‐Korpela, M. (2011) · Metabolomics · doi:10.1007/s11306-011-0343-y · Cited by 92
Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity
Rodríguez‐Cuenca, S., Barbarroja, N., & Vidal‐Puig, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.09.021 · Cited by 92
Fengler, V. H., Macheiner, T., Kessler, S. M., Czepukojc, B., Gemperlein, K., Müller, R., Kiemer, A. K., Magnes, C., Haybaeck, J., Lackner, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155163 · Cited by 84
Integrative metabolomics science in Alzheimer’s disease: Relevance and future perspectives
Lista, S., González‐Domínguez, R., López‐Ortiz, S., González‐Domínguez, Á., Menéndez, H., Martín-Hernández, J., Lucía, A., Emanuele, E., Centonze, D., Imbimbo, B. P., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101987 · Cited by 82
Klein, R. L., Hammad, S. M., Baker, N. L., Hunt, K. J., Gadban, M. M. A., Cleary, P. A., Virella, G., & Lopes-Virella, M. F. (2014) · Metabolism · doi:10.1016/j.metabol.2014.07.001 · Cited by 81
Reducing sphingolipid synthesis orchestrates global changes to extend yeast lifespan
Liu, J., Huang, X., Withers, B. R., Blalock, E., Liu, K., & Dickson, R. C. (2013) · Aging Cell · doi:10.1111/acel.12107 · Cited by 71
Manoel-Caetano, F. S., Xavier, D. J., Evangelista, A. F., Takahashi, P., Collares, C. V. A., Puthier, D., Foss‐Freitas, M. C., Foss, M. C., Donadi, E. A., Passos, G. A. S., et al. (2012) · Gene · doi:10.1016/j.gene.2012.09.090 · Cited by 73
Hall, A. M., Soufi, N., Chambers, K. T., Chen, Z., Schweitzer, G. G., McCommis, K. S., Erion, D. M., Graham, M. J., Su, X., & Finck, B. N. (2014) · Diabetes · doi:10.2337/db13-1502 · Cited by 70
Rabinowich, L., Fishman, S., Hubel, E., Thurm, T., Park, W., Pewzner‐Jung, Y., Saroha, A., Erez, N., Halpern, Z., Futerman, A. H., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.030 · Cited by 71
Patel, S. A., Hoehn, K. L., Lawrence, R. T., Sawbridge, L., Talbot, N. A., Tomsig, J. L., Turner, N., Cooney, G. J., Whitehead, J. P., Kraegen, E. W., et al. (2012) · Endocrinology · doi:10.1210/en.2012-1368 · Cited by 66
dos Santos, A. X. D. S., Riezman, I., Aguilera-Romero, A., David, F. P. A., Piccolis, M., Loewith, R., Schaad, O., & Riezman, H. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-03-0851 · Cited by 70
Stearoyl-CoA Desaturase: A Vital Checkpoint in the Development and Progression of Obesity
Poudyal, H., & Brown, L. (2011) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153011796429826 · Cited by 76
Advances in Proteomic and Metabolomic Profiling of Neurodegenerative Diseases
Schuh, A. F. S., Bieger, A., Borelli, W. V., Portley, M. K., Awad, P. S., & Bandrés‐Ciga, S. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.792227 · Cited by 80
Targeting Ceramide Synthesis to Reverse Insulin Resistance
Schmitz-Peiffer, C. (2010) · Diabetes · doi:10.2337/db10-0912 · Cited by 62
Divergent Role of Sphingosine 1-Phosphate on Insulin Resistance
Fayyaz, S., Japtok, L., & Kleuser, B. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000362990 · Cited by 68
Kamili, A., Wat, E., Chung, R. W., Tandy, S., Weir, J. M., Meikle, P. J., & Cohn, J. S. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-90 · Cited by 61
de la Monte, S. M. (2012) · PubMed · Cited by 66
Yeast as a model system for studying lipid homeostasis and function
Santos, A. X. S., & Riezman, H. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.07.033 · Cited by 70
Ceramides are fuel gauges on the drive to cardiometabolic disease
Wilkerson, J. L., Tatum, S. M., Holland, W. L., & Summers, S. A. (2024) · Physiological Reviews · doi:10.1152/physrev.00008.2023 · Cited by 67
Self-citationRetinol saturase modulates lipid metabolism and the production of reactive oxygen species
Pang, X.-Y., Wang, S., Jurczak, M. J., Shulman, G. I., & Moise, A. R. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.09.009 · Cited by 58
Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis
Yang, R., Pan, Q., Liu, X., Zhou, D., Xin, F., Zhao, Z., Zhang, R.-N., Zeng, J., Qiao, L., Hu, C., et al. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1118-0 · Cited by 57
Chu, S., Sun, R., Gu, X., Chen, L., Liu, M., Guo, H., Ju, S., Vatsalya, V., Feng, W., McClain, C. J., et al. (2020) · Hepatology · doi:10.1002/hep.31321 · Cited by 55
Bcl10 Links Saturated Fat Overnutrition with Hepatocellular NF-κB Activation and Insulin Resistance
Beek, M. V., Oravecz-Wilson, K. I., Delekta, P. C., Gu, S., Li, X., Jin, X., Apel, I. J., Konkle, K. S., Feng, Y., Teitelbaum, D. H., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.04.006 · Cited by 51
Widmann, P., Reverter, A., Weikard, R., Suhre, K., Hammon, H. M., Albrecht, E., & Kuehn, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124574 · Cited by 50
Sphingolipids in mitochondria—from function to disease
Jamil, M., & Cowart, L. A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1302472 · Cited by 48
Edmunds, L. R., Xie, B., Mills, A. M., Huckestein, B. R., Undamatla, R., Murali, A., Pangburn, M. M., Martin, J. L., SIPULA, I. J., Kaufman, B. A., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101051 · Cited by 51
Ablation of Dihydroceramide Desaturase Confers Resistance to Etoposide-Induced Apoptosis In Vitro
Siddique, M. M., Bikman, B. T., Wang, L., Li, Y., Reinhardt, E., Shui, G., Wenk, M. R., & Summers, S. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044042 · Cited by 42
Self-citationGlycosylated sphingolipids and progression to kidney dysfunction in type 1 diabetes
Lopes-Virella, M. F., Baker, N. L., Hunt, K. J., Hammad, S. M., Arthur, J. M., Virella, G., & Klein, R. L. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.03.005 · Cited by 43
Mass spectrometric analysis of neutral sphingolipids: methods, applications, and limitations.
Farwanah, H., Kolter, T., & Sandhoff, K. (2011) · Biochimica et Biophysica Acta · doi:10.1016/j.bbalip.2011.05.011 · Cited by 34
Gburcik, V., Cleasby, M. E., & Timmons, J. A. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00463.2012 · Cited by 41
Wang, S., Yin, J., Liu, Z., Liu, X., Tian, G., Xin, X., Qin, Y., & Feng, X. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123211 · Cited by 45
Sphingolipids at the Crossroads of NAFLD and Senescence
Nikolova‐Karakashian, M. (2018) · Advances in cancer research · doi:10.1016/bs.acr.2018.05.002 · Cited by 39
Batova, A., Altomare, D., Creek, K. E., Naviaux, R. K., Wang, L., Li, K., Green, E., Williams, R. T., Naviaux, J. C., Diccianni, M. B., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172632 · Cited by 34
The expanding role of sphingolipids in lipid droplet biogenesis
Deevska, G. M., & Nikolova‐Karakashian, M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.07.008 · Cited by 41
Hebbar, P., Nizam, R., Melhem, M., Alkayal, F., Elkum, N. B., John, S. E., Tuomilehto, J., Alsmadi, O. A., & Thanaraj, T. A. (2018) · Journal of Lipid Research · doi:10.1194/jlr.p080218 · Cited by 36
Sphk2−/− mice are protected from obesity and insulin resistance
Ravichandran, S., Finlin, B. S., Kern, P. A., & Özcan, S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.12.012 · Cited by 39
Li, S., Zeng, X., Zhou, X., Wang, H., Jo, E., Robinson, S. R., Xu, A., & Ye, J. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.021 · Cited by 32
Choi, H., Koh, H. W. L., Zhou, L., He, C., Loh, T. P., Rizi, E. P., Toh, S. A., Ronnett, G. V., Huang, B. E., & Khoo, C. M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00379 · Cited by 37
ANGPTL8 in metabolic homeostasis: more friend than foe?
Guo, C. Y., Wang, C., Deng, X., He, J., Yang, L., & Yuan, G. (2021) · Open Biology · doi:10.1098/rsob.210106 · Cited by 31
Lipid mediators of insulin signaling in diabetic kidney disease
Mitrofanova, A. V., Sosa, M. A., & Fornoni, A. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00379.2019 · Cited by 32
Hepatocyte-derived GDF15 suppresses feeding and improves insulin sensitivity in obese mice
Xie, B., Murali, A., Vandevender, A. M., Chen, J. W., Silva, A. G., Bello, F. M., Chuan, B. W., Bahudhanapati, H., SIPULA, I. J., Dedousis, N. L., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105569 · Cited by 29
Reducing signs of aging and increasing lifespan by drug synergy
Huang, X., Liu, J., Withers, B. R., Samide, A. J., Leggas, M. L., & Dickson, R. C. (2013) · Aging Cell · doi:10.1111/acel.12090 · Cited by 28
Acetylation of sphingosine kinase 1 regulates cell growth and cell-cycle progression
Yu, H., Shao, Y., Gao, L., Zhang, L., Guo, K., Wu, C., Hu, X., & Duan, H. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.117 · Cited by 28
Sigrüener, A., Wolfrum, C., Boettcher, A., Kopf, T., Liebisch, G., Orsó, E., & Schmitz, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178368 · Cited by 23
Role of Sphingolipid Signaling in Glomerular Diseases: Focus on DKD and FSGS
Mitrofanova, A. V., Drexler, Y. R., Merscher, S., & Fornoni, A. (2020) · Journal of Cellular Signaling · doi:10.33696/signaling.1.013 · Cited by 23
Ruh, H., Sandhoff, R., Meyer, B., Gretz, N., & Hopf, C. (2013) · Analytical Chemistry · doi:10.1021/ac400931u · Cited by 23
Federico, L., Yang, L., Brandon, J. A., Panchatcharam, M., Ren, H., Mueller, P., Sunkara, M., Escalante‐Alcalde, D., Morris, A. J., & Smyth, S. S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198063 · Cited by 23
Liebisch, G., & Scherer, M. (2011) · Journal of Chromatography B · doi:10.1016/j.jchromb.2011.10.037 · Cited by 25
Konjac glucomannans attenuate diet-induced fat accumulation on livers and its regulation pathway
Shang, W., Li, H., Strappe, P., Zhou, Z., & BLANCHARD, C. L. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.11.006 · Cited by 21
Ceramide and Insulin Resistance: How Should the Issue Be Approached?
Górski, J. (2012) · Diabetes · doi:10.2337/db12-1157 · Cited by 19
Contreras-Zentella, M. L., & Hernández-Muñoz, R. E. (2021) · Antioxidants · doi:10.3390/antiox10111729 · Cited by 20
Changes in Serum Sphingomyelin After Roux-en-Y Gastric Bypass Surgery Are Related to Diabetes Status
Carlsson, E. R., Grundtvig, J. L. G., Madsbad, S., & Fenger, M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00172 · Cited by 20
Obanda, D. N., Yu, Y., Wang, Z. Q., & Cefalu, W. T. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.01.007 · Cited by 17
Ye, J., Ye, X., Jiang, W., Lu, C., Geng, X., Zhao, C., Ma, Y., Yang, P., Lam, S. M., Shui, G., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108699 · Cited by 19
Bacquer, O. L., Combe, K., Montaurier, C., Salles, J., Giraudet, C., Patrac, V., Domingues-Faria, C., Guillet, C., Louche, K., Boirie, Y., et al. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700128 · Cited by 16
Role of gut microbiota in the development of non-alcoholic fatty liver disease
Wang, X., Xia, J., & Jiang, C. (2019) · Liver Research · doi:10.1016/j.livres.2019.01.006 · Cited by 18
Metadata
- Authors
- Summers, S. A.
- Affiliations
- National University of Singapore (SG)
- Corresponding author
- Summers, Scott A
- ORCID
- Summers, Scott A
- Venue
- Current Opinion in Lipidology
- Published
- 2010-04
- Volume
- 21
- Issue
- 2
- Pages
- 128-135
- ISSN
- 0957-9672 (ISSN-L)
- OpenAlex
- W2023794522
- Cited by
- 136
- References
- 73
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 5 · 2023: 5 · 2022: 3 · 2021: 5 · 2020: 5 · 2019: 7 · 2018: 10 · 2017: 11 · 2016: 7 · 2015: 9 · 2014: 11 · 2013: 9 · 2012: 22
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Lipidology (publishedVersion)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK081456, R01DK081456)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- sphingolipids, insulin resistance, ceramide, glucosylceramide, hepatic steatosis, obesity, diabetes mellitus, skeletal muscle insulin signaling, adipose tissue, obesity-associated inflammation, metabolic disorders, nutrient deprivation
- MeSH terms
- Animals, Humans, Insulin, Insulin Resistance, Obesity, Sphingolipids, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.